<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TRJ</journal-id>
<journal-id journal-id-type="hwp">sptrj</journal-id>
<journal-title>Textile Research Journal</journal-title>
<issn pub-type="ppub">0040-5175</issn>
<issn pub-type="epub">1746-7748</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0040517512468815</article-id>
<article-id pub-id-type="publisher-id">10.1177_0040517512468815</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Keratin sponge/hydrogel II: Active agent delivery</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cardamone</surname><given-names>Jeanette M</given-names></name>
<xref ref-type="corresp" rid="corresp1-0040517512468815"/>
</contrib>
</contrib-group>
<aff id="aff1-0040517512468815">USDA, 600 East Mermaid Ln, Wyndmoor, PA 19038, USA</aff>
<author-notes>
<corresp id="corresp1-0040517512468815">Jeanette M Cardamone, USDA, 600 East Mermaid Ln, Wyndmoor, PA 19038, USA. Email: <email>jan.cardamone@ars.usda.gov</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2013</year>
</pub-date>
<volume>83</volume>
<issue>9</issue>
<fpage>917</fpage>
<lpage>927</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Keratin sponge/hydrogels, described in Part I as the products of oxidation and reduction hydrolysis of fine and coarse wool fibers, were examined as excipient-platforms for the delivery of riboflavin. By absorption through well-defined pores and networks, saturated moisture equilibrium was reached within one hour with swelling ratios of 3.7–5.7. Riboflavin uptake by the four different keratin sponge/hydrogels was from 27.9 to 224 µg. Within 60 minutes, reductive keratin sponge/hydrogels from fine and coarse wool, and the oxidative species from fine wool, released 100% riboflavin at 1.58–1.73% per minute and oxidative sponge/hydrogel from coarse wool released 48% riboflavin at 0.8% riboflavin per minute. Rates of riboflavin release were faster within the initial 10 minutes where reductive sponge/hydrogels released 80–84% riboflavin at 8.0–8.4% per minute and oxidative sponge/hydrogels released 26–63% riboflavin at 2.6–6.3% per minute. Riboflavin delivery at timed intervals was examined with the Korsmeyer–Peppas mathematical model for fractional release. Release patterns followed quasi-Fickian diffusion of the drug by transport through channels and voids. All keratin sponge/hydrogels functioned as site-specific agents with two-stage delivery where immediate release of riboflavin was followed by a period of prolonged, lower dosage release. Swelling studies, the mobility of water, and the behavior of riboflavin release favorably framed keratin sponge/hydrogels as microfluidic devices with implied applications for advanced biomedical and biotechnological applications.</p>
</abstract>
<kwd-group>
<kwd>keratin</kwd>
<kwd>sponge/hydrogel</kwd>
<kwd>riboflavin delivery/ diffusion drug release</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Hydrogel biopolymers – insoluble, three-dimensional, and hydrophilic – are capable of absorbing and releasing large amounts of fluids while maintaining structural integrity through internal physical and molecular associations, crosslinking, and crystallite entanglements. Applications include contact lenses, biosensor membranes, artificial heart liners, artificial skin material, cell cultivation, and drug delivery devices.<sup><xref ref-type="bibr" rid="bibr1-0040517512468815">1</xref></sup> Sponge/hydrogels of keratin protein provide super-molecular, dense aggregates in a porous matrix. These materials functioned as biocompatible orthopedic supports to restore form and function.<sup><xref ref-type="bibr" rid="bibr2-0040517512468815">2</xref></sup> Implanted keratin was biocompatible and useful for cell tissue and scaffolds for fibroblasts as anti-thrombogenic biomaterial.<sup><xref ref-type="bibr" rid="bibr3-0040517512468815">3</xref><xref ref-type="bibr" rid="bibr4-0040517512468815"/>–<xref ref-type="bibr" rid="bibr5-0040517512468815">5</xref></sup> Keratin gels, mats, scaffolds, and films are of significant interest for biotechnological and biomedical applications.<sup><xref ref-type="bibr" rid="bibr6-0040517512468815">6</xref><xref ref-type="bibr" rid="bibr7-0040517512468815"/><xref ref-type="bibr" rid="bibr8-0040517512468815"/><xref ref-type="bibr" rid="bibr9-0040517512468815"/><xref ref-type="bibr" rid="bibr10-0040517512468815"/><xref ref-type="bibr" rid="bibr11-0040517512468815"/><xref ref-type="bibr" rid="bibr12-0040517512468815"/><xref ref-type="bibr" rid="bibr13-0040517512468815"/>–<xref ref-type="bibr" rid="bibr14-0040517512468815">14</xref></sup> Keratin functional platforms adhere naturally to keratinous substrates, such as hair, skin, and nails, and can deliver beneficial agents for health, medicine, and personal care. As a solid matrix, keratin sponge/hydrogel can be examined for implantation where silicone-derived materials are typically used.<sup><xref ref-type="bibr" rid="bibr14-0040517512468815">14</xref><xref ref-type="bibr" rid="bibr15-0040517512468815"/><xref ref-type="bibr" rid="bibr16-0040517512468815"/><xref ref-type="bibr" rid="bibr17-0040517512468815"/><xref ref-type="bibr" rid="bibr18-0040517512468815"/><xref ref-type="bibr" rid="bibr19-0040517512468815"/><xref ref-type="bibr" rid="bibr20-0040517512468815"/><xref ref-type="bibr" rid="bibr21-0040517512468815"/><xref ref-type="bibr" rid="bibr22-0040517512468815"/>–<xref ref-type="bibr" rid="bibr23-0040517512468815">23</xref></sup></p>
<p>In Part I keratin protein was isolated from the hydrolysis of wool fiber and formed into sponge/hydrogels. These materials were examined as ionic platforms with properties characteristically requisite for agent-uptake and delivery. Porosity and differences in topologies were documented in scanning electron micrographs. These materials exhibited thermal and mechanical stability, shown by differential scanning calorimetry (DSC) and rheology measurements. Viscoelastic behavior, measured by storage modulus G′, and loss modulus, G″, characterized them as strong gels. In Part II we examined keratin sponge/hydrogel as excipient material by documenting uptake and release of moisture, uptake of riboflavin, and release of riboflavin according to kinetic diffusion models. We applied diffusional solute release mechanisms to analyze the functional release of riboflavin solubilized in simulated gastric fluid (SGF). Riboflavin (CAS number 83-88-5), vitamin B2, a yellow, hydrophilic, tricyclic molecule, is an easily absorbed micronutrient essential to health in humans and animals for activating vitamin B6, vitamin B9 (folate), vitamin B3 (niacin), and vitamin K. It is essential for healing and recovery from burns, wounds, surgery, and other injuries and is essential for proper immune system functioning, and reinforcing the body’s natural antibody reserves. The US recommended daily allowance (RDA) for most adults is 2.4 micrograms (<ext-link ext-link-type="uri" xlink:href="http://www.nal.usda.gov/fnic/DRI/DRI_Thiamin/87-122_150.pdf">http://www.nal.usda.gov/fnic/DRI/DRI_Thiamin/87-122_150.pdf</ext-link>). The benefits of treating keratin substrates with riboflavin are well documented.<sup><xref ref-type="bibr" rid="bibr24-0040517512468815">24</xref><xref ref-type="bibr" rid="bibr25-0040517512468815"/>–<xref ref-type="bibr" rid="bibr26-0040517512468815">26</xref></sup></p>
<p>Riboflavin is soluble in SGF (pH 1.2) and slightly soluble in water (0.01 g/100 mL at 25℃). The isoalloxazine ring of riboflavin at the N-10 position contains a ribityl carbohydrate chain connected to four hydroxyl groups. As a neutral molecule, riboflavin at low pH can behave as a polyprotic acid or base. In SGF, pH 1.2, riboflavin’s basic character promotes reactivity with keratin through electrostatic interaction. It was assumed that the binding between riboflavin and keratin was non-covalent.<sup><xref ref-type="bibr" rid="bibr27-0040517512468815">27</xref>,<xref ref-type="bibr" rid="bibr28-0040517512468815">28</xref></sup> Others have reported riboflavin loading and release from hydrogel polymer networks. In vitro release studies of riboflavin in SGF were reported with release profiles of riboflavin entrapped in calcium alginate and polyglycidyl methacrylate sodium alginate-grafted hydrogels.<sup><xref ref-type="bibr" rid="bibr29-0040517512468815">29</xref></sup> Patel and Amiji<sup><xref ref-type="bibr" rid="bibr30-0040517512468815">30</xref></sup> investigated the release of riboflavin in SGF from chitosan-polyethylene oxide (PEO) hydrogel for in vitro site-specific delivery to the stomach and reported the swelling ratio (weight of the swollen hydrogel/weight of the dry hydrogel) and release kinetics by applying the Korsmeyer–Peppas model, <italic>M<sub>t</sub></italic>/<italic>M</italic><sub>∞</sub> = <italic>k</italic>.<italic>t<sup>n</sup></italic>.</p>
<sec id="sec1-0040517512468815"><title>Experimental details</title>
<sec id="sec2-0040517512468815"><title>Morphology features</title>
<p>In Part I we isolated ARS DD and M1-1 keratin sponge/hydrogels with the intact chemical and microstructure of native keratin. ARS DD appeared mat-like and fibrous and M1-1 appeared smooth and homogeneous. We found that keratin sponge/hydrogels formed by oxidation hydrolysis (ARS DD) and reduction hydrolysis (M1-1) were amphoteric, swelling-controlled systems capable of dynamic absorption and desorption. <xref ref-type="fig" rid="fig1-0040517512468815">Figure 1</xref> shows a crenulated structure and associated microfibers with channels of discrete, interconnected, porous walls and voids.
<fig id="fig1-0040517512468815" position="float"><label>Figure 1.</label><caption><p>Keratin sponge/hydrogels: ARS DD (a)–(e) where (a)–(c) are hydrated, (d) is dehydrated, and (e) is lyophilized powder; M1-1 (f)–(j) where (f)–(h) are hydrated, (i) is dehydrated, and (j) is lyophilized powder.</p></caption><graphic xlink:href="10.1177_0040517512468815-fig1.tif"/>
</fig></p>
</sec>
</sec>
<sec id="sec3-0040517512468815"><title>Response to moisture</title>
<p>In four independent experiments, fully hydrated keratin sponge/hydrogels in triplicate, 300–500 mg each, were vacuum-oven dried to the bone-dry state in 12 mL Pyrex® standard weighing bottles (Corning, external 24/12 taper joint). At timed intervals throughout drying, constant dry weights to within +/− 10 mg were recorded. Moisture release was determined from sample weights of fully hydrated samples (<italic>W<sub>s</sub></italic>), and weights at prescribed times of hydration (<italic>W<sub>t</sub></italic>) from
<disp-formula id="disp-formula1-0040517512468815"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math1-0040517512468815"><mml:mrow><mml:mtext>Moisture release</mml:mtext><mml:mo>,</mml:mo><mml:mi> </mml:mi><mml:mo>%</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic alternate-form-of="disp-formula1-0040517512468815" xlink:href="10.1177_0040517512468815-eq1.tif"/></disp-formula>
</p>
<p>The dried samples were placed in a closed system above a saturated K<sub>2</sub>CrO<sub>4</sub> salt solution for swelling until moisture equilibrium was reached.<sup><xref ref-type="bibr" rid="bibr31-0040517512468815">31</xref></sup> The Swelling ratio, <italic>Q</italic>,<sup><xref ref-type="bibr" rid="bibr30-0040517512468815">30</xref>,<xref ref-type="bibr" rid="bibr32-0040517512468815">32</xref></sup> was calculated using sample dry weight, <italic>W<sub>d</sub></italic>, and the weight of the swollen sample, <italic>W<sub>s</sub></italic>, in the equation
<disp-formula id="disp-formula2-0040517512468815"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math2-0040517512468815"><mml:mrow><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><graphic alternate-form-of="disp-formula2-0040517512468815" xlink:href="10.1177_0040517512468815-eq2.tif"/></disp-formula>
</p>
<sec id="sec4-0040517512468815"><title>Absorption of simulated gastric fluid</title>
<p>Oven-dried replicate samples, each of fine and coarse keratin sponge/hydrogels, ARS DD and M1-1, were exposed to SGF, pH 1.2, supplied as 0.2% w/w NaCl in 0.7% v/v HCl (Ricca Chemical Company, Texas). Each sample was placed into individual 15 mL perforated, conical BD Falcon® tubes to which were added 12 mL SGF. The samples were agitated in a 37℃ shaker bath. At 10 minute intervals, the samples were withdrawn and centrifuged for 10 minutes on a fixed-speed Cole-Palmer Centrifuge at 3400 rpm to remove unabsorbed SGF. Uptake of SGF was measured from swelling ratio, <italic>Q</italic>.</p>
</sec>
</sec>
<sec id="sec5-0040517512468815"><title>Absorption of riboflavin</title>
<p>A 6.5 ppm riboflavin stock solution (1.14 mg (-)-riboflavin powder, C<sub>7</sub>H<sub>2</sub>ON<sub>4</sub>O<sub>6,</sub> Sigma-Aldrich Company, St. Louis, MO, 376.36 g/mole) was prepared in 215 ml SGF. Aliquot concentrations of the stock solution, 0–6.5 ppm, were used to generate a standard curve for riboflavin absorbance detection at 265 nm. The oven-dried, keratin sponge/hydrogel replicates of fine and coarse ARS DD and M1-1 were submersed in the riboflavin solution and placed into an Orbit Environ Shaker from Lab-Line Instruments, Inc. (Melrose Park, IL) for shaking at 37℃ until equilibrium saturation was reached. The riboflavin-impregnated samples were vacuum-dried at 50℃. Then the dry riboflavin-impregnated samples were individually exposed to 50 ml SGF with a volume of 1 ml for every 0.5 mg of sample at 37℃ with shaking. Aliquots of each sample solution were taken every 2 minutes for the first 30 minutes, and then every 5 minutes for the first hour from which 1 ml aliquots were removed for ultraviolet (UV) detection of riboflavin. The aliquots were each transferred to a QS 283 quartz cuvette from Hellma Analytics and analyzed using a Cary 50 Conc UV-Visible Spectrophotometer from Varian Instruments (Walnut Creek, CA). The amount of riboflavin, mg, in SGF was found from the slope equation of the standard curve for absorbance versus riboflavin concentration. The uptake of riboflavin at timed intervals was determined as the swelling ratio, <italic>Q</italic>.<sup><xref ref-type="bibr" rid="bibr33-0040517512468815">33</xref></sup></p>
<sec id="sec6-0040517512468815"><title>Mathematical release models</title>
<p>In order to clarify the interaction of water within the hydrophilic keratin sponge/hydrogels, mathematical models for controlled release were applied as zero-order, first-order, Hixson–Crowell, Higuchi, and Korsmeyer–Peppas expressions. We treated the riboflavin release data accordingly as cumulative percentage drug release versus time (zero-order kinetic model); log cumulative of percentage drug remaining versus time (first-order kinetic model); cube root of drug percentage remaining in matrix versus time (Hixson–Crowell cube root law); cumulative percentage drug release versus square root of time (Higuchi model); and log cumulative percentage drug release versus log time (Korsmeyer–Peppas model).<sup><xref ref-type="bibr" rid="bibr34-0040517512468815">34</xref><xref ref-type="bibr" rid="bibr35-0040517512468815"/><xref ref-type="bibr" rid="bibr36-0040517512468815"/><xref ref-type="bibr" rid="bibr37-0040517512468815"/><xref ref-type="bibr" rid="bibr38-0040517512468815"/><xref ref-type="bibr" rid="bibr39-0040517512468815"/><xref ref-type="bibr" rid="bibr40-0040517512468815"/>–<xref ref-type="bibr" rid="bibr41-0040517512468815">41</xref></sup> Zero-order rate equations assumed the rate of drug release was independent of its concentration in the equation, <italic>C</italic> = <italic>k<sub>o</sub> t</italic>, where <italic>k<sub>o</sub></italic> is a zero-order rate constant expressed in units of concentration/ time, <italic>t</italic>. The first-order rate equation described the release from a system where release rate was concentration dependent: Log <italic>C</italic> = Log <italic>C<sub>o</sub></italic> − <italic>k t</italic> / 2.303, where <italic>C<sub>o</sub></italic> is the initial concentration of the drug and <italic>k</italic> is first-order constant. The Hixson–Crowell model described the release from systems where there was a change in surface area: <italic>Q<sub>o</sub></italic><sup>1/3</sup> − <italic>Q<sub>t</sub></italic><sup>1/3 </sup>= <italic>k<sub>HC</sub></italic>, where <italic>Q<sub>t</sub></italic> was the amount of drug released in time <italic>t<sub>o</sub></italic>, <italic>Q<sub>o</sub></italic> was the initial amount of the drug, and <italic>k<sub>HC</sub></italic> was the rate constant. Higuchi described drug release from a solid substance by assuming that diffusion of the dissolved drug through the matrix was the rate-controlling stage in the overall release process. Accordingly, the square root of a time-dependent process was based on the Fickian diffusion process in the equation <italic>Q</italic> = <italic>kt</italic><sup>1/2</sup>, where <italic>k</italic> was the constant reflecting the design variables of the system, utilizing the equation, <italic>M<sub>t</sub></italic> / <italic>M</italic><sub>∞</sub> = <italic>kt</italic><sup>1/2</sup>, and <italic>M<sub>t</sub></italic> was the cumulative weight-amount of drug at time <italic>t</italic>. The term, <italic>k</italic>, was the Higuchi release constant determined by plotting the cumulative percent of drug release against the square root of time in hours to find the slope of the corresponding line. The Korsmeyer–Peppas model, <italic>M<sub>t</sub></italic> / <italic>M</italic><sub>∞</sub> = <italic>k</italic>.<italic>t<sup>n</sup></italic>, <italic>M<sub>t</sub></italic> / <italic>M</italic><sub>∞</sub> represented fractional drug release at time <italic>t</italic>, with <italic>k</italic> the rate release constant and <italic>n</italic> the slope (release exponent) characterizing the transport mechanism dependent on the geometry of the device. The Korsmeyer–Peppas drug release rate constant (<italic>k</italic>, %/h) was calculated as the slope of linear regression lines fitted to the log <italic>Mt</italic> / <italic>M</italic><sub>∞,</sub> where <italic>M</italic><sub>∞</sub> was the total amount of drug absorbed or released at equilibrium (after an infinite time, <italic>t</italic>).<sup><xref ref-type="bibr" rid="bibr36-0040517512468815">36</xref></sup> To characterize diffusional behavior, tortuosity, and porosity of the sponge/hydrogels, which influence drug release, we found <italic>n</italic> from the log–log plots, as a determinant of Fickian diffusion. Values of <italic>n</italic> &lt; 0.5 indicated quasi-Fickian diffusion.</p>
</sec>
</sec>
<sec id="sec7-0040517512468815" sec-type="results"><title>Results and discussion</title>
<sec id="sec8-0040517512468815"><title>Moisture absorption and release</title>
<p>All keratin sponge/hydrogels released 50% moisture within 70 minutes, as shown in <xref ref-type="fig" rid="fig2-0040517512468815">Figure 2(a)</xref>. Differences in pore size, type, tortuosity, and surface roughness did not secure the entrapment of water at the conditions applied for drying.
<fig id="fig2-0040517512468815" position="float"><label>Figure 2.</label><caption><p>Dynamic moisture release (a) and absorption (b).</p></caption><graphic xlink:href="10.1177_0040517512468815-fig2.tif"/>
</fig></p>
<p>When the dried samples were rehydrated, as shown in <xref ref-type="fig" rid="fig2-0040517512468815">Figure 2(b)</xref>, moisture equilibrium was achieved within 241–562 hours with 41–47% absorption for M1-1 samples. ARS DD samples achieved 62–74% moisture equilibrium within the same time period, following the same kinetic profiles for moisture absorption. With moisture absorption and release predictably the same for all keratin sponge/hydrogels, selection of a particular type would be based upon the moisture content and the ability for a host to accommodate the size of the swollen material that can be regulated, based on the extent of exposure to moisture, as shown in <xref ref-type="table" rid="table1-0040517512468815">Table 1</xref>.
<table-wrap id="table1-0040517512468815" position="float"><label>Table 1.</label><caption><p>Swelling ratio, <italic>Q</italic>: cumulative moisture absorption from the dry state</p></caption>
<graphic alternate-form-of="table1-0040517512468815" xlink:href="10.1177_0040517512468815-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>10 h</th>
<th>25 h</th>
<th>70 h</th>
<th>218 h</th>
<th>562 h</th>
</tr></thead>
<tbody align="left">
<tr>
<td>M1-1 fine</td>
<td>1.14 ± 0.03</td>
<td>1.27 ± 0.04</td>
<td>1.31 ± 0.07</td>
<td>1.40 ± 0.03</td>
<td>1.50 ± 0.05</td>
</tr>
<tr>
<td>M1-1 coarse</td>
<td>1.16 ± 0.07</td>
<td>1.27 ± 0.06</td>
<td>1.31 ± 0.06</td>
<td>1.39 ± 0.11</td>
<td>1.43 ± 0.04</td>
</tr>
<tr>
<td>ARS DD fine</td>
<td>1.17 ± 0.14</td>
<td>1.33 ± 0.06</td>
<td>1.41 ± 0.02</td>
<td>1.55 ± 0.05</td>
<td>1.66 ± 0.05</td>
</tr>
<tr>
<td>ARS DD coarse</td>
<td>1.17 ± 0.11</td>
<td>1.35 ± 0.10</td>
<td>1.45 ± 0.11</td>
<td>1.60 ± 0.06</td>
<td>1.74 ± 0.03</td>
</tr>
</tbody>
</table>
</table-wrap></p>
</sec>
<sec id="sec9-0040517512468815"><title>Swelling in simulated gastric fluid</title>
<p>Swelling in SGF was appreciably greater than swelling in moisture from a saturated environment. By placing keratin sponge/hydrogels in an acidic environment in SGF, it was expected that the sorption of SGF (pH 1.2) would follow wool dyeing in acidic medium where wool is protonated for attraction of anionic dye. Equilibrium saturation was reached with higher swelling ratios, as shown in <xref ref-type="fig" rid="fig3-0040517512468815">Figure 3</xref> and <xref ref-type="table" rid="table2-0040517512468815">Table 2</xref>, indicating the pH-sensitivity of the materials. Kinetic profiles were similar, reaching equilibrium saturation within 55 minutes. M1-1 fine with more compact structure swelled less, reaching equilibrium saturation within 60 minutes.
<fig id="fig3-0040517512468815" position="float"><label>Figure 3.</label><caption><p>Absorption of simulated gastric fluid by keratin sponge/hydrogels.</p></caption><graphic xlink:href="10.1177_0040517512468815-fig3.tif"/>
</fig>
<table-wrap id="table2-0040517512468815" position="float"><label>Table 2.</label><caption><p>Swelling ratio, <italic>Q</italic>, cumulative absorption of simulated gastric fluid by keratin sponge/hydrogels from dry state to equilibrium saturation</p></caption>
<graphic alternate-form-of="table2-0040517512468815" xlink:href="10.1177_0040517512468815-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>5 minutes</th>
<th>30 minutes</th>
<th>55 minutes</th>
</tr></thead>
<tbody align="left">
<tr>
<td>M1-1 fine</td>
<td>1.76 ± 0.56</td>
<td>3.54 ± 0.03</td>
<td>3.68 ± 0.04</td>
</tr>
<tr>
<td>M1-1 coarse</td>
<td>2.04 ± 0.45</td>
<td>4.89 ± 0.21</td>
<td>5.73 ± 0.45</td>
</tr>
<tr>
<td>ARS DD fine</td>
<td>2.20 ± 0.35</td>
<td>4.28 ± 0.62</td>
<td>5.56 ± 0.61</td>
</tr>
<tr>
<td>ARS DD coarse</td>
<td>2.16 ± 0.42</td>
<td>4.11 ± 0.31</td>
<td>4.56 ± 0.31</td>
</tr>
</tbody>
</table>
</table-wrap></p>
</sec>
<sec id="sec10-0040517512468815"><title>Diffusional release of riboflavin</title>
<p>Kinetic swelling in <xref ref-type="fig" rid="fig4-0040517512468815">Figure 4</xref> was rapid up to 20 minutes. Maximum swelling for M1-1 coarse was achieved within 3 minutes. Within 20 minutes, swelling followed the order: M1-1 coarse &gt;ARS DD coarse = ARS DD fine &gt;M1-1 fine. Note that equilibrium swelling was achieved within 20 minutes in riboflavin/SGF compared to 55 minutes for swelling in SGF. We attributed the difference in kinetic behavior to electrostatic interaction of riboflavin and keratin at pH 1.2.
<fig id="fig4-0040517512468815" position="float"><label>Figure 4.</label><caption><p>Riboflavin absorption by keratin sponge/hydrogels.</p></caption><graphic xlink:href="10.1177_0040517512468815-fig4.tif"/>
</fig></p>
<p><xref ref-type="table" rid="table3-0040517512468815">Table 3</xref> represents the maximum capacity of each dry keratin sponge/hydrogel sample to take up riboflavin in SGF. The total amount of riboflavin uptake in infinite time, <italic>M∞</italic>, was taken to be the value at which the release curve reached an asymptote.
<table-wrap id="table3-0040517512468815" position="float"><label>Table 3.</label><caption><p>Uptake of riboflavin</p></caption>
<graphic alternate-form-of="table3-0040517512468815" xlink:href="10.1177_0040517512468815-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th colspan="8">Maximum uptake of riboflavin</th>
</tr>
<tr><th colspan="2">M1-1 fine</th>
<th colspan="2">M1-1 coarse</th>
<th colspan="2">ARS DD fine</th>
<th colspan="2">ARS DD coarse</th>
</tr>
<tr><th>Riboflavin (µg) <italic>M</italic><sub>∞</sub></th>
<th>Riboflavin (µg/gram sponge)</th>
<th>Riboflavin (µg) <italic>M</italic><sub>∞</sub></th>
<th>Riboflavin (µg/gram sponge)</th>
<th>Riboflavin (µg) <italic>M</italic><sub>∞</sub></th>
<th>Riboflavin (µg/gram sponge)</th>
<th>Riboflavin (µg) <italic>M</italic><sub>∞</sub></th>
<th>Riboflavin (µg/gram sponge)</th>
</tr></thead>
<tbody align="left">
<tr>
<td>27.9</td>
<td>104.1</td>
<td>59.0</td>
<td>224.4</td>
<td>91.3</td>
<td>179.4</td>
<td>63.7</td>
<td>179.4</td>
</tr>
</tbody>
</table>
</table-wrap></p>
</sec>
</sec>
<sec id="sec11-0040517512468815"><title>Kinetic profiles for riboflavin release</title>
<p><xref ref-type="table" rid="table4-0040517512468815">Table 4</xref> represents the absolute amount of riboflavin released and fractional release with rates of release at timed intervals up to 60 minutes.
<table-wrap id="table4-0040517512468815" position="float"><label>Table 4.</label><caption><p>Release of riboflavin</p></caption>
<graphic alternate-form-of="table4-0040517512468815" xlink:href="10.1177_0040517512468815-table4.tif"/>
<table frame="hsides"><thead align="left">
<tr><th colspan="7">Release of riboflavin</th>
</tr>
<tr><th rowspan="2"/><th colspan="3">M1-1 fine</th>
<th colspan="3">M1-1 coarse</th>
</tr>
<tr><th>Absolute release (µg), <italic>M<sub>T</sub></italic></th>
<th>Fractional release, <italic>M<sub>T</sub></italic>/<italic>M</italic>∞</th>
<th>Rate of release (% riboflavin release/min)</th>
<th>Absolute release (µg), <italic>M<sub>T</sub></italic></th>
<th>Fractional release, <italic>M<sub>T</sub></italic>/<italic>M</italic>∞</th>
<th>Rate of release (% riboflavin release/min)</th>
</tr></thead>
<tbody align="left">
<tr>
<td>0–10 min</td>
<td>23.4</td>
<td>84%</td>
<td>8.4</td>
<td>47.1</td>
<td>80%</td>
<td>8.0</td>
</tr>
<tr>
<td>10–30 min</td>
<td>4.5</td>
<td>16%</td>
<td>0.8</td>
<td>6.1</td>
<td>10%</td>
<td>0.5</td>
</tr>
<tr>
<td>30–60 min</td>
<td>1.2</td>
<td>4%</td>
<td>0.13</td>
<td>2.6</td>
<td>4%</td>
<td>0.13</td>
</tr>
<tr>
<td>0–60 min</td>
<td>29.1</td>
<td>104%</td>
<td>1.73</td>
<td>55.9</td>
<td>95%</td>
<td>1.58</td>
</tr>
<tr>
<td colspan="3">ARS DD fine</td>
<td colspan="3">ARS DD coarse</td>
</tr>
<tr>
<td>0–10 min</td>
<td>57.3</td>
<td>63%</td>
<td>6.3</td>
<td>16.3</td>
<td>26%</td>
<td>2.6</td>
</tr>
<tr>
<td>10–30 min</td>
<td>17.8</td>
<td>19%</td>
<td>0.95</td>
<td>10.0</td>
<td>16%</td>
<td>0.8</td>
</tr>
<tr>
<td>30–60 min</td>
<td>15.8</td>
<td>7%</td>
<td>0.23</td>
<td>4.4</td>
<td>7%</td>
<td>0.23</td>
</tr>
<tr>
<td>0–60 min</td>
<td>90.8</td>
<td>99%</td>
<td>1.65</td>
<td>30.6</td>
<td>48%</td>
<td>0.8</td>
</tr>
</tbody>
</table>
</table-wrap></p>
<p>It is clear that both M1-1 sponges and ARS DD fine sponge were able to release nearly all of the riboflavin absorbed. It should be noted that the ARS DD coarse sponge/hydrogel released riboflavin at the slowest rate and can function for slow, sustained release of riboflavin.</p>
<p><xref ref-type="fig" rid="fig5-0040517512468815">Figure 5</xref> shows the rate patterns for release of riboflavin at the timed intervals.
<fig id="fig5-0040517512468815" position="float"><label>Figure 5.</label><caption><p>Fractional release of riboflavin, minutes: (a) 0–10; (b) 10–30; (c) 30–60; (d) – 0–60.</p></caption><graphic xlink:href="10.1177_0040517512468815-fig5.tif"/>
</fig></p>
<p>Riboflavin released percentages, from <xref ref-type="table" rid="table4-0040517512468815">Table 4</xref>, are included in <xref ref-type="table" rid="table5-0040517512468815">Table 5</xref> with Korsmeyer–Peppas coefficients, <italic>k</italic> (rate release constant), and <italic>n</italic> (release exponent). Values of <italic>n</italic> (also shown in <xref ref-type="table" rid="table6-0040517512468815">Table 6</xref>) were used to identify the kinetic-mechanistic-diffusion model, which was determined by the highest correlation values, <italic>R</italic>.
<table-wrap id="table5-0040517512468815" position="float"><label>Table 5.</label><caption><p>Application of Korsmeyer–Peppas kinetic-mechanistic-diffusion model</p></caption>
<graphic alternate-form-of="table5-0040517512468815" xlink:href="10.1177_0040517512468815-table5.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Riboflavin released, %</th>
<th><italic>k</italic></th>
<th><italic>n</italic></th>
<th><italic>R</italic></th>
</tr></thead>
<tbody align="left">
<tr>
<td rowspan="4">M1-1 fine</td>
<td>0–10 min</td>
<td>84%</td>
<td>1.921</td>
<td>0.210</td>
<td>0.990</td>
</tr>
<tr>
<td>10–30 min</td>
<td>16%</td>
<td>1.723</td>
<td>0.159</td>
<td>0.975</td>
</tr>
<tr>
<td>30–60 min</td>
<td>4%</td>
<td>1.242</td>
<td>0.062</td>
<td>0.893</td>
</tr>
<tr>
<td>0–60 min</td>
<td>104%</td>
<td>1.749</td>
<td>0.157</td>
<td>0.964</td>
</tr>
<tr>
<td rowspan="4">M1-1 coarse</td>
<td>0–10 min</td>
<td>80%</td>
<td>2.166</td>
<td>0.243</td>
<td>0.994</td>
</tr>
<tr>
<td>10–30 min</td>
<td>10%</td>
<td>1.566</td>
<td>0.105</td>
<td>0.944</td>
</tr>
<tr>
<td>30–60 min</td>
<td>4%</td>
<td>1.432</td>
<td>0.075</td>
<td>0.975</td>
</tr>
<tr>
<td>0–60 min</td>
<td>95%</td>
<td>1.828</td>
<td>0.148</td>
<td>0.910</td>
</tr>
<tr>
<td rowspan="4">ARS DD fine</td>
<td>0–10 min</td>
<td>63%</td>
<td>3.312</td>
<td>0.326</td>
<td>0.996</td>
</tr>
<tr>
<td>10–30 min</td>
<td>19%</td>
<td>2.663</td>
<td>0.231</td>
<td>0.984</td>
</tr>
<tr>
<td>30–60 min</td>
<td>7%</td>
<td>3.241</td>
<td>0.290</td>
<td>0.970</td>
</tr>
<tr>
<td>0–60 min</td>
<td>99%</td>
<td>3.051</td>
<td>0.276</td>
<td>0.992</td>
</tr>
<tr>
<td rowspan="4">ARS DD coarse</td>
<td>0–10 min</td>
<td>26%</td>
<td>8.976</td>
<td>0.356</td>
<td>0.981</td>
</tr>
<tr>
<td>10–30 min</td>
<td>16%</td>
<td>11.641</td>
<td>0.451</td>
<td>0.959</td>
</tr>
<tr>
<td>30–60 min</td>
<td>7%</td>
<td>5.311</td>
<td>0.226</td>
<td>0.923</td>
</tr>
<tr>
<td>0–60 min</td>
<td>48%</td>
<td>9.215</td>
<td>0.370</td>
<td>0.987</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table6-0040517512468815" position="float"><label>Table 6.</label><caption><p>Comparison of riboflavin mechanistic release models</p></caption>
<graphic alternate-form-of="table6-0040517512468815" xlink:href="10.1177_0040517512468815-table6.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">Time: 2–10 minutes</th>
<th colspan="3">Zero order</th>
<th colspan="3">First order</th>
<th colspan="3">Hixson–Crowell</th>
<th colspan="3">Higuchi</th>
<th colspan="4">Korsmeyer–Peppas</th>
</tr>
<tr><th><italic>k</italic></th>
<th>S.D.</th>
<th><italic>R</italic></th>
<th><italic>k</italic></th>
<th>S.D.</th>
<th><italic>R</italic></th>
<th><italic>k</italic></th>
<th><italic>S.D.</italic></th>
<th><italic>R</italic></th>
<th><italic>k</italic></th>
<th><italic>S.D.</italic></th>
<th><italic>R</italic></th>
<th><italic>k</italic></th>
<th><italic>n</italic></th>
<th><italic>S.D.</italic></th>
<th><italic>R</italic></th>
</tr></thead>
<tbody align="left">
<tr>
<td>M1-1 fine</td>
<td>179.5</td>
<td>9.623</td>
<td>0.966</td>
<td>1.0769</td>
<td>0.0582</td>
<td>0.953</td>
<td>–0.22</td>
<td>0.012</td>
<td>0.960</td>
<td>107.7</td>
<td>9.63</td>
<td>0.988</td>
<td>1.222</td>
<td>0.210</td>
<td>0.058</td>
<td>0.990</td>
</tr>
<tr>
<td>M1-1 coarse</td>
<td>187.3</td>
<td>10.21</td>
<td>0.966</td>
<td>1.0769</td>
<td>0.067</td>
<td>0.953</td>
<td>–0.32</td>
<td>0.017</td>
<td>0.917</td>
<td>113.7</td>
<td>10.21</td>
<td>0.9780</td>
<td>1.234</td>
<td>0.243</td>
<td>0.067</td>
<td>0.990</td>
</tr>
<tr>
<td>ARS DD fine</td>
<td>188.0</td>
<td>10.16</td>
<td>0.952</td>
<td>1.6373</td>
<td>0.090</td>
<td>0.929</td>
<td>–0.45</td>
<td>0.024</td>
<td>0.931</td>
<td>113.6</td>
<td>10.16</td>
<td>0.988</td>
<td>1.124</td>
<td>0.325</td>
<td>0.09</td>
<td>0.996</td>
</tr>
<tr>
<td>ARS DD coarse</td>
<td>79.89</td>
<td>4.32</td>
<td>0.950</td>
<td>1.7916</td>
<td>0.099</td>
<td>0.908</td>
<td>–0.32</td>
<td>0.017</td>
<td>0.923</td>
<td>48.04</td>
<td>4.32</td>
<td>0.976</td>
<td>0.483</td>
<td>0.356</td>
<td>0.099</td>
<td>0.981</td>
</tr>
<tr>
<td><bold>Time: 2–30 minutes</bold></td>
</tr>
<tr>
<td>M1-1 fine</td>
<td>71.91</td>
<td>11.42</td>
<td>0.881</td>
<td>0.379</td>
<td>0.062</td>
<td>0.832</td>
<td>–0.08</td>
<td>0.013</td>
<td>0.849</td>
<td>69.71</td>
<td>11.42</td>
<td>0.959</td>
<td>1.134</td>
<td>0.181</td>
<td>0.062</td>
<td>0.989</td>
</tr>
<tr>
<td>M1-1 coarse</td>
<td>61.59</td>
<td>10.52</td>
<td>0.881</td>
<td>0.379</td>
<td>0.063</td>
<td>0.832</td>
<td>–0.1</td>
<td>0.017</td>
<td>0.727</td>
<td>61.57</td>
<td>10.52</td>
<td>0.883</td>
<td>1.023</td>
<td>0.180</td>
<td>0.063</td>
<td>0.989</td>
</tr>
<tr>
<td>ARS DD fine</td>
<td>82.13</td>
<td>13.01</td>
<td>0.885</td>
<td>0.578</td>
<td>0.096</td>
<td>0.809</td>
<td>–0.17</td>
<td>0.028</td>
<td>0.837</td>
<td>79.66</td>
<td>13.01</td>
<td>0.965</td>
<td>0.998</td>
<td>0.280</td>
<td>0.096</td>
<td>0.988</td>
</tr>
<tr>
<td>ARS DD coarse</td>
<td>52.72</td>
<td>7.94</td>
<td>0.980</td>
<td>0.8429</td>
<td>0.131</td>
<td>0.926</td>
<td>–0.17</td>
<td>0.025</td>
<td>0.951</td>
<td>49.00</td>
<td>7.94</td>
<td>0.981</td>
<td>0.536</td>
<td>0.381</td>
<td>0.131</td>
<td>0.982</td>
</tr>
<tr>
<td><bold>Time: 2–60 minutes</bold></td>
</tr>
<tr>
<td>M1-1 fine</td>
<td>35.68</td>
<td>11.87</td>
<td>0.729</td>
<td>0.1785</td>
<td>0.062</td>
<td>0.668</td>
<td>–0.04</td>
<td>0.014</td>
<td>0.689</td>
<td>48.25</td>
<td>11.87</td>
<td>0.878</td>
<td>1.043</td>
<td>0.157</td>
<td>0.062</td>
<td>0.964</td>
</tr>
<tr>
<td>M1-1 coarse</td>
<td>28.83</td>
<td>10. 35</td>
<td>0.729</td>
<td>0.1785</td>
<td>0.060</td>
<td>0.668</td>
<td>–0.04</td>
<td>0.016</td>
<td>0.582</td>
<td>39.99</td>
<td>10.35</td>
<td>0.793</td>
<td>0.947</td>
<td>0.148</td>
<td>0.060</td>
<td>0.964</td>
</tr>
<tr>
<td>ARS DD fine</td>
<td>55.04</td>
<td>16.57</td>
<td>0.891</td>
<td>0.1785</td>
<td>0.107</td>
<td>0.783</td>
<td>–0.1</td>
<td>0.032</td>
<td>0.823</td>
<td>70.95</td>
<td>16.57</td>
<td>0.975</td>
<td>0.995</td>
<td>0.275</td>
<td>0.107</td>
<td>0.992</td>
</tr>
<tr>
<td>ARS DD coarse</td>
<td>33.03</td>
<td>9.88</td>
<td>0.902</td>
<td>0.4557</td>
<td>0.144</td>
<td>0.804</td>
<td>–0.09</td>
<td>0.029</td>
<td>0.842</td>
<td>42.30</td>
<td>9.88</td>
<td>0.975</td>
<td>0.481</td>
<td>0.370</td>
<td>0.144</td>
<td>0.987</td>
</tr>
</tbody>
</table>
</table-wrap></p>
<p><xref ref-type="table" rid="table6-0040517512468815">Table 6</xref> was constructed to elucidate diffusion by comparing relevant parameters describing the best fit of the data acquired by applying the various mechanistic models. In <xref ref-type="table" rid="table6-0040517512468815">Table 6</xref> for the Korsmeyer–Peppas model, a value of <italic>n</italic> = &lt;0.5, indicated that the time-release of riboflavin through the sponge/hydrogel followed a quasi-Fickian diffusion mechanism. When determining <italic>n</italic>, it was necessary to use only the initial part of the release curve where <italic>M<sub>t</sub></italic> / <italic>M</italic>∞ &lt; 0.6. When analyzing data of drug release from porous systems, the <italic>n</italic> value would most likely be less than 0.5 due to a combination of mechanisms based on diffusion through a swollen matrix and through with water-filled pores that would shift the release exponent toward smaller values.<sup><xref ref-type="bibr" rid="bibr34-0040517512468815">34</xref>,<xref ref-type="bibr" rid="bibr36-0040517512468815">36</xref><xref ref-type="bibr" rid="bibr37-0040517512468815"/><xref ref-type="bibr" rid="bibr38-0040517512468815"/><xref ref-type="bibr" rid="bibr39-0040517512468815"/><xref ref-type="bibr" rid="bibr40-0040517512468815"/>–<xref ref-type="bibr" rid="bibr41-0040517512468815">41</xref></sup> From <xref ref-type="table" rid="table6-0040517512468815">Table 6</xref>, the Korsmeyer–Peppas model was clearly the best match with greater than 95% correlation for every sample across all time intervals. We assumed that <italic>n</italic> &lt; 0.5 values could be explained as a result of the combined mechanisms (diffusion partially through a swollen matrix and partially through water-filled pores).<sup><xref ref-type="bibr" rid="bibr38-0040517512468815">38</xref></sup> The Hixson–Crowell model was slightly less strongly correlated than the Higuchi model, indicating that riboflavin transport was facilitated by a diffusion mechanism as opposed to dissolution. The fact that the zero-order release model was a little more strongly correlated than the first-order release model indicated that the drug release rate was independent of the concentration of dissolved substance. Riboflavin release was best described for both M1-1 fine and ARS DD fine by an unspecified diffusion mechanism, and for M1-1 coarse and ARS DD coarse, as a quasi-pore-size-dependent Fickian diffusion mechanism. Based on these observations, the keratin sponge/hydrogels can be considered for controlled release when an initial immediate-release dose followed by an extended-release dose is prescribed. Keratin sponge/hydrogels exhibited dual-release in delivering higher dosages immediately and lower dosages over prolonged time.</p>
</sec>
<sec id="sec12-0040517512468815" sec-type="conclusions"><title>Conclusions</title>
<p>In Part II, investigations showed the potential of keratin sponge/hydrogel to function as renewable biomaterial for in vitro delivery of the model drug, riboflavin. Uniquely amphoteric and highly functionalized keratin is positioned favorably when compared to other natural and synthetic sponge/hydrogels used as drug delivery systems. These keratin materials proved capable of swelling and drug release in the low pH environment of stomach fluid. They exhibited dual-control kinetics for riboflavin release. Formed in Part I from oxidation and reduction of wool fibers, they demonstrated high elasticity with reversible deformation, and the ability to entrap and release moisture under stress while maintaining their structural integrity. Typical hydrogel behavior was demonstrated in Part II by sorption studies showing that from equilibrium saturation, these materials released up to 83–93% moisture at comparable rates within 350 hours. All sponge/hydrogels proved responsive to pH change, evidenced by greater swelling in SGF. From SGF, fine and coarse oxidative and reductive species released 100% riboflavin (29–91 µg) within 60 minutes, except for coarse oxidative sponge/hydrogel, which released 31 µg riboflavin with fractional release, 48%. Within 10 minutes, rates of release followed the order: M1-1 fine &gt;M1-1 coarse &gt;ARS DD fine &gt;ARS DD, releasing respectively from 84% to 26% riboflavin. Implications can be drawn for controlled, timed, sustained release. Applied kinetic mathematical models showed that Fickian diffusion control for riboflavin release was most effective in ARS DD sponge/hydrogels with highest diffusional exponents, <italic>n</italic>, according to Korsmeyer–Peppas<italic>.</italic> Highest rates of release of riboflavin, <italic>k</italic>, exhibited by fine sponge/hydrogels indicated highest interaction between the drug and porous matrix. The release data of unbound moisture and riboflavin from the keratin sponge/hydrogels, fit to release curves, proved that the hydrogels served as diffusion barriers to release riboflavin mainly by Fickian diffusion-control, whereby water diffusion into the hydrogel occurred much faster than the relaxation of the polymer chains. We have shown that swelling kinetics occurred according to the diffusion control as a mechanism for release and that sponge/hydrogels acted as diffusion barriers to make them useful for slow release with retention of riboflavin.<sup><xref ref-type="bibr" rid="bibr39-0040517512468815">39</xref></sup> Conclusions from this study should invite in vitro and in vivo studies as needed to explore possibilities for synergistic medical treatments utilizing keratin sponge/hydrogels.</p>
</sec>
</body>
<back><ack>
<title>Acknowledgments</title>
<p>The author recognizes the support of Adam Meyers for data collection and assimilation in applying mathematical models, Michelle Hall for data organization and collation, and Douglas Soroka and Guoping Bao for scanning electron micrographs.</p></ack>
<sec id="sec14-0040517512468815"><title>Funding</title>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0040517512468815"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>MI</given-names></name><name><surname>Smith</surname><given-names>AM</given-names></name><name><surname>Das</surname><given-names>AK</given-names></name><etal/></person-group>. <article-title>Self- assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells</article-title>. <source>Biomaterials</source> <year>2009</year>; <volume>30</volume>: <fpage>2523</fpage>–<lpage>2530</lpage>.</citation></ref>
<ref id="bibr2-0040517512468815"><label>2</label><citation citation-type="other"><comment>Peplow PV, Dias SN and Roddick-Lanzilotta AD. <italic>Orthopedic materials derived from keratin</italic>. Patent 7,297,342 B2, USA, 2009</comment>.</citation></ref>
<ref id="bibr3-0040517512468815"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>WH</given-names></name><name><surname>Ha</surname><given-names>WS</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Relationships between antithrombogenicity and surface energy of regenerated silk fibroin films</article-title>. <source>Fibers Polym</source> <year>2001</year>; <volume>2</volume>: <fpage>58</fpage>–<lpage>63</lpage>.</citation></ref>
<ref id="bibr4-0040517512468815"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamauchi</surname><given-names>K</given-names></name><name><surname>Maniwa</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name></person-group>. <article-title>Cultivation of fibroblast cells on keratin-coated substrata</article-title>. <source>J Biomater Sci Polym</source> <year>1998</year>; <volume>9</volume>: <fpage>259</fpage>–<lpage>270</lpage>.</citation></ref>
<ref id="bibr5-0040517512468815"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tachibana</surname><given-names>A</given-names></name><name><surname>Furuta</surname><given-names>Y</given-names></name><name><surname>Takeshima</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Fabrication of wool keratin sponge scaffolds for long-term cell cultivation</article-title>. <source>J Biotech</source> <year>2002</year>; <volume>93</volume>: <fpage>165</fpage>–<lpage>170</lpage>.</citation></ref>
<ref id="bibr6-0040517512468815"><label>6</label><citation citation-type="other"><comment>Blanchard CR, Timmons SF and Smith RA. <italic>Keratin-based hydrogel for biomedical applications and method of production</italic>. Patent 2001/0009675 A, USA, 2001</comment>.</citation></ref>
<ref id="bibr7-0040517512468815"><label>7</label><citation citation-type="other"><comment>Timmons SF, Blanchard CR and Smith RA. <italic>Keratin-based tissue engineering scaffold</italic>. Patent 6,432,435 B, USA, 2002</comment>.</citation></ref>
<ref id="bibr8-0040517512468815"><label>8</label><citation citation-type="other"><comment>Siller-Jackson AJ, Van Dyke ME, Timmons SF, et al. <italic>Keratin-based powders and hydrogel for pharmaceutical applications</italic>. Patent 6,544,548 B, USA, 2003</comment>.</citation></ref>
<ref id="bibr9-0040517512468815"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>K</given-names></name><name><surname>Shibayama</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Preparation and physiochemical properties of compression-molded keratin films</article-title>. <source>Biomaterials</source> <year>2004</year>; <volume>25</volume>: <fpage>2265</fpage>–<lpage>2275</lpage>.</citation></ref>
<ref id="bibr10-0040517512468815"><label>10</label><citation citation-type="other"><comment>Kelly RJ, Ali MA, Roddick-Lanzilotta AD, et al. <italic>Composite materials containing keratin</italic>. Patent 7,767,756 B2, USA, 2010</comment>.</citation></ref>
<ref id="bibr11-0040517512468815"><label>11</label><citation citation-type="other"><comment>Kelly RJ, Roddick-Lanzilotta AD and Ali MA. <italic>Wound care products containing keratin</italic>. Patent 7,732,574 B2, USA, 2010</comment>.</citation></ref>
<ref id="bibr12-0040517512468815"><label>12</label><citation citation-type="other"><comment>Kelly RJ, Roddick-Lansilotta AD, Rankin DA, et al. <italic>Production of biopolymer film, fibre, foam and adhesive materials from soluble S-sulfonated keratin derivatives</italic>. Patent 0069541 A, USA, 2009</comment>.</citation></ref>
<ref id="bibr13-0040517512468815"><label>13</label><citation citation-type="other"><comment>Kelly RJ, Worth GH, Roddick-Lanzilotta AD, et al. <italic>Production of soluble keratin derivatives</italic>. Patent 7,148,327 B2, USA, 2006</comment>.</citation></ref>
<ref id="bibr14-0040517512468815"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tachibana</surname><given-names>A</given-names></name><name><surname>Nishikawa</surname><given-names>Y</given-names></name><name><surname>Nishino</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Modified keratin sponge: binding of bone morphogenetic protein-2 and osteoblasty differentiation</article-title>. <source>J Biosci Bioeng</source> <year>2006</year>; <volume>102</volume>: <fpage>425</fpage>–<lpage>429</lpage>.</citation></ref>
<ref id="bibr15-0040517512468815"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caruso</surname><given-names>J</given-names></name><name><surname>Sivas</surname><given-names>SL</given-names></name><name><surname>Meyer</surname><given-names>JL</given-names></name></person-group>. <article-title>Straightforward approach for screening silicone gels of varying functionality for use in cosmetic ingredient delivery</article-title>. <source>J Cosmetic Sci</source> <year>2008</year>; <volume>59</volume>: <fpage>368</fpage>–<lpage>369</lpage>.</citation></ref>
<ref id="bibr16-0040517512468815"><label>16</label><citation citation-type="other"><comment>Gueret JL. <italic>Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least, one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent</italic>. Patent 6,063,398, USA, 2000</comment>.</citation></ref>
<ref id="bibr17-0040517512468815"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kotzar</surname><given-names>G</given-names></name><name><surname>Fraes</surname><given-names>M</given-names></name><name><surname>Abel</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Evaluation of MEMS materials of construction for implantable medical devices</article-title>. <source>Biomaterials</source> <year>2002</year>; <volume>23</volume>: <fpage>2737</fpage>–<lpage>2750</lpage>.</citation></ref>
<ref id="bibr18-0040517512468815"><label>18</label><citation citation-type="other"><comment>Morgan L and Millard ML. <italic>Medical sponges and wipes with a barrier impermeable to infectious agents</italic>. Patent 5,009,652, USA, 1991</comment>.</citation></ref>
<ref id="bibr19-0040517512468815"><label>19</label><citation citation-type="other"><comment>Bara I and Mellul M. <italic>Cosmetic composition for the make-up of the skin, containing at least one silicone wax and process for its preparation</italic>. Patent 5,478,555, USA, 1995</comment>.</citation></ref>
<ref id="bibr20-0040517512468815"><label>20</label><citation citation-type="other"><comment>Fujimoto S and Sugiyama M. <italic>Method for making a cellular rubber, cellular rubbers obtained by the method, and cosmetic puffs made of the cellular rubber</italic>. Patent 5,434<italic>,</italic>194, USA, 1995</comment>.</citation></ref>
<ref id="bibr21-0040517512468815"><label>21</label><citation citation-type="other"><comment>Martin JC, Kilburn RS, Teague KL, et al. <italic>Method of manufacturing a sponge device</italic>. Patent 6,852<italic>,</italic>258 B1, USA, 2005</comment>.</citation></ref>
<ref id="bibr22-0040517512468815"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XZ</given-names></name><name><surname>Yang</surname><given-names>YY</given-names></name><name><surname>Chung</surname><given-names>TS</given-names></name><etal/></person-group>. <article-title>Preparation and characterization of fast response macroporous poly(n-isopropylacrylamide) hydrogels</article-title>. <source>Langmuir</source> <year>2001</year>; <volume>17</volume>: <fpage>6094</fpage>–<lpage>6099</lpage>.</citation></ref>
<ref id="bibr23-0040517512468815"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MG</given-names></name><name><surname>Davies</surname><given-names>DM</given-names></name></person-group>. <article-title>Breast augmentation: Part I – review of the silicone prosthesis</article-title>. <source>J Plast Reconstructive Aesthetic Surg</source> <year>2013</year>; <volume>63</volume>: <fpage>1761</fpage>–<lpage>1768</lpage>.</citation></ref>
<ref id="bibr24-0040517512468815"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bajpai</surname><given-names>SK</given-names></name><name><surname>Sonkusley</surname><given-names>J</given-names></name></person-group>. <article-title>Dynamic release of riboflavin from a colon-targeted delivery device: an in vitro study</article-title>. <source>React Funct Polym</source> <year>2003</year>; <volume>55</volume>: <fpage>197</fpage>–<lpage>210</lpage>.</citation></ref>
<ref id="bibr25-0040517512468815"><label>25</label><citation citation-type="other"><comment>Noll M and Schulze ZWE. <italic>Hair-protective cosmetics</italic>. WO 2011000649 (A2), 2011</comment>.</citation></ref>
<ref id="bibr26-0040517512468815"><label>26</label><citation citation-type="other"><comment>Weser G and Henke M. <italic>Novel agent for treating keratin fibres</italic>. WO 2006021350, 2006</comment>.</citation></ref>
<ref id="bibr27-0040517512468815"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becvar</surname><given-names>J</given-names></name><name><surname>Palmer</surname><given-names>G</given-names></name></person-group>. <article-title>The binding of flavin derivatives to the riboflavin-binding protein of egg white</article-title>. <source>J Biol Chem</source> <year>1982</year>; <volume>257</volume>: <fpage>5607</fpage>–<lpage>5617</lpage>.</citation></ref>
<ref id="bibr28-0040517512468815"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamat</surname><given-names>BP</given-names></name><name><surname>Seetharamappa</surname><given-names>J</given-names></name><name><surname>Melwanki</surname><given-names>MB</given-names></name></person-group>. <article-title>Spectroscopic studies on the interaction of riboflavin with bovine serum albumin</article-title>. <source>Ind J Biochem Biophys</source> <year>2004</year>; <volume>41</volume>: <fpage>173</fpage>–<lpage>178</lpage>.</citation></ref>
<ref id="bibr29-0040517512468815"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abd El-Ghaffar</surname><given-names>MA</given-names></name><name><surname>Hashem</surname><given-names>MS</given-names></name><name><surname>El-Awady</surname><given-names>MK</given-names></name><etal/></person-group>. <article-title>pH-sensitive sodium alginate hydrogels for riboflavin controlled release</article-title>. <source>Carbohydr Polym</source> <year>2012</year>; <volume>89</volume>: <fpage>667</fpage>–<lpage>675</lpage>.</citation></ref>
<ref id="bibr30-0040517512468815"><label>30</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>VR</given-names></name><name><surname>Amiji</surname><given-names>MM</given-names></name></person-group>. <article-title>pH sensitive swelling and drug-release properties of chitosan-poly(ethylene oxide) semi-penetrating polymer network</article-title>. <source><italic>In:</italic> Hydrogels and biodegradable polymers for bioapplications, ACS Symposium Series 627. Chapter 17</source>, <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Chemical Society</publisher-name>, <year>1996</year><fpage>209</fpage>–<lpage>220</lpage>.</citation></ref>
<ref id="bibr31-0040517512468815"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>JF</given-names></name></person-group>. <article-title>Humidity control in the laboratory using salt solutions – a review</article-title>. <source>J Appl Chem</source> <year>1967</year>; <volume>17</volume>: <fpage>241</fpage>–<lpage>245</lpage>.</citation></ref>
<ref id="bibr32-0040517512468815"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kortesuo</surname><given-names>P</given-names></name><name><surname>Ahola</surname><given-names>M</given-names></name><name><surname>Kangas</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters</article-title>. <source>Int J Pharm</source> <year>2001</year>; <volume>221</volume>: <fpage>107</fpage>–<lpage>114</lpage>.</citation></ref>
<ref id="bibr33-0040517512468815"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>RL</given-names></name><name><surname>Paton</surname><given-names>RL</given-names></name></person-group>. <article-title>A study of riboflavin metabolism in the American roach by fluorescence microscopy</article-title>. <source>J Cell Comp Physiol</source> <year>1942</year>; <volume>19</volume>: <fpage>373</fpage>–<lpage>376</lpage>.</citation></ref>
<ref id="bibr34-0040517512468815"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peppas</surname><given-names>N</given-names></name></person-group>. <article-title>Analysis of Fickian and non-Fickian drug release from polymers</article-title>. <source>Pharm Acta Helv</source> <year>1985</year>; <volume>60</volume>: <fpage>110</fpage>–<lpage>111</lpage>.</citation></ref>
<ref id="bibr35-0040517512468815"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>VR</given-names></name><name><surname>Amiji</surname><given-names>MM</given-names></name></person-group>. <article-title>Preparation and characterization of freeze-dried chitosan- poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach</article-title>. <source>Pharm Res</source> <year>1996</year>; <volume>13</volume>: <fpage>588</fpage>–<lpage>592</lpage>.</citation></ref>
<ref id="bibr36-0040517512468815"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korsmeyer</surname><given-names>RW</given-names></name><name><surname>Gurny</surname><given-names>R</given-names></name><name><surname>Doelker</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Mechanisms of solute release from porous hydrophilic polymers</article-title>. <source>Int J Pharm</source> <year>1983</year>; <volume>15</volume>: <fpage>25</fpage>–<lpage>35</lpage>.</citation></ref>
<ref id="bibr37-0040517512468815"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brannon-Peppas</surname><given-names>L</given-names></name><name><surname>Peppas</surname><given-names>NA</given-names></name></person-group>. <article-title>Solute and penetrant diffusion in swellable polymers. IX. The mechanisms of drug release from pH-sensitive swelling-controlled-systems</article-title>. <source>J Controlled Release</source> <year>1989</year>; <volume>8</volume>: <fpage>2667</fpage>–<lpage>2674</lpage>.</citation></ref>
<ref id="bibr38-0040517512468815"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peppas</surname><given-names>NA</given-names></name><name><surname>Franson</surname><given-names>NM</given-names></name></person-group>. <article-title>The swelling interface number as a criterion for prediction of diffusion solute release mechanisms in swellable polymers</article-title>. <source>J Polym Sci</source> <year>1983</year>; <volume>21</volume>: <fpage>983</fpage>–<lpage>997</lpage>.</citation></ref>
<ref id="bibr39-0040517512468815"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>T</given-names></name></person-group>. <article-title>Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices</article-title>. <source>J Pharm Sci</source> <year>1963</year>; <volume>52</volume>: <fpage>1145</fpage>–<lpage>1149</lpage>.</citation></ref>
<ref id="bibr40-0040517512468815"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hixson</surname><given-names>AW</given-names></name><name><surname>Crowell</surname><given-names>JH</given-names></name></person-group>. <article-title>Dependence of reaction velocity upon surface and agitation (I) theoretical consideration</article-title>. <source>Ind Eng Chem</source> <year>1931</year>; <volume>23</volume>: <fpage>923</fpage>–<lpage>931</lpage>.</citation></ref>
<ref id="bibr41-0040517512468815"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franso</surname><given-names>NM</given-names></name><name><surname>Peppas</surname><given-names>NA</given-names></name></person-group>. <article-title>Influence of copolymer composition on non-Fickian water transport through glassy copolymers</article-title>. <source>J Appl Polym Sci</source> <year>1983</year>; <volume>28</volume>: <fpage>1299</fpage>–<lpage>1231</lpage>.</citation></ref>
</ref-list>
<app-group><app id="app1-0040517512468815"><title/>
<sec id="sec13-0040517512468815"><title>Appendix</title>
<p><def-list id="list1-0040517512468815"><def-item><term>ARS DD</term><def>
<p>keratin sponge/ hydrogel formed by oxidation hydrolysis of wool fiber</p></def></def-item><def-item><term>M1-1</term><def>
<p>keratin sponge/ hydrogel formed by reduction hydrolysis of wool fiber</p></def></def-item><def-item><term>SGF</term><def>
<p>simulated gastric fluid</p></def></def-item><def-item><term>DSC</term><def>
<p>differential scanning calorimetry</p></def></def-item><def-item><term>G′</term><def>
<p>storage modulus</p></def></def-item><def-item><term>G″</term><def>
<p>loss modulus</p></def></def-item><def-item><term><italic>W<sub>s</sub></italic></term><def>
<p>weight of fully hydrated sample</p></def></def-item><def-item><term><italic>W<sub>t</sub></italic></term><def>
<p>weight of hydrated sample at time, <italic>t</italic></p></def></def-item><def-item><term><italic>Q</italic></term><def>
<p>swelling ratio</p></def></def-item><def-item><term><italic>C</italic><italic>k<sub>o</sub> t</italic></term> <def>
<p>zero-order rate equations</p></def></def-item><def-item><term><italic>C</italic></term><def>
<p>concentration</p></def></def-item><def-item><term><italic>k<sub>o</sub></italic></term><def>
<p>zero-order rate constant expressed in units of concentration/ time, <italic>t</italic></p></def></def-item><def-item><term><italic>C<sub>o</sub></italic></term><def>
<p>is the initial concentration of the drug</p></def></def-item><def-item><term><italic>Q<sub>o</sub></italic><sup>1/3</sup>−<italic>Q<sub>t</sub></italic><sup>1/3</sup></term><def>
<p><italic>k<sub>HC</sub></italic> = the Hixson–Crowell release model equation</p></def></def-item><def-item><term><italic>Q<sub>t</sub></italic></term><def>
<p>amount of drug released in time <italic>t<sub>o</sub></italic></p></def></def-item><def-item><term><italic>k<sub>HC</sub></italic></term><def>
<p>the Hixson–Crowell rate constant.</p></def></def-item><def-item><term><italic>Q</italic><italic>kt</italic><sup>1/2</sup></term><def>
<p>Fickian diffusion rate equation</p></def></def-item><def-item><term><italic>M<sub>t</sub></italic> / <italic>M</italic>∞ <italic>k.t<sup>n</sup></italic></term><def>
<p>Korsmeyer–Peppas model</p></def></def-item><def-item><term><italic>M<sub>t</sub></italic> / <italic>M</italic>∞</term><def>
<p>fractional drug release in the Korsmeyer– Peppas model</p></def></def-item><def-item><term>Zero-order rate equation</term><def>
<p><italic>C</italic> = <italic>k<sub>o</sub> t</italic></p></def></def-item><def-item><term>First-order rate equation</term><def>
<p>Log <italic>C </italic>= Log <italic>C<sub>o</sub></italic> − <italic>k t</italic> / 2.303</p></def></def-item><def-item><term>Hixson–Crowell equation</term><def>
<p><italic>Q<sub>o</sub></italic><sup>1/3</sup> − <italic>Q<sub>t</sub></italic><sup>1/3</sup>= <italic>k<sub>HC</sub></italic></p></def></def-item><def-item><term>Fickian diffusion process</term><def>
<p><italic>Q</italic> = <italic>kt</italic><sup>1/2</sup></p></def></def-item><def-item><term>Korsmeyer–Peppas equation</term><def>
<p><italic>M<sub>t</sub></italic> / <italic>M</italic>∞ = <italic>k.t<sup>n</sup></italic></p></def></def-item></def-list></p>
</sec></app></app-group>
</back>
</article>